TREATMENT OF SOCIAL PHOBIA

社交恐惧症是一种普遍但知之甚少的焦虑症 以经历强烈的焦虑为特征的，并且经常 避免涉及他人监督的社交场合。社交 恐惧症不仅会导致高度的主观痛苦，而且 也会导致孤独感，学业和职业能力下降 表现、受限的职业和个人发展、饮酒 虐待和抑郁。与其他焦虑症一样，焦虑 经历社交恐惧症的特征是躯体(身体 感觉)、认知(思想)和公开行为(回避) 功能。 社交恐惧症的治疗信息远远落后于此 其他恐惧症的症状。两种截然不同的治疗方法，药物 β-肾上腺素能阻滞剂的治疗与行为 两种脱敏疗法都显示出相当可观的效果 我保证。然而，目前还没有公开的尝试 比较这两种处理方法，或者检查它们的组合 治疗社交恐惧症的有效性。 建议的研究是脱敏的治疗比较。 再加上安慰剂，β-受体阻滞剂阿替洛尔 脱敏、阿替洛尔和安慰剂。180 受试者将参加为期3个月的治疗阶段和6个月的 月随访阶段。结果将允许评估 阿替洛尔的有效性、脱敏和潜在的 阿替洛尔联合脱敏的协同作用。 此外，这些治疗的耐久性将是 下定决心。这项研究将提供有关 社交恐惧症的临床治疗及其影响 对社会和全球功能的治疗。

Social phobia is a prevalent yet poorly understood anxiety disorder characterized by the experience of intense anxiety in, and often avoidance of social situations involving scrutiny by others. Social phobia not only leads to a high degree of subjective distress, but also can result in loneliness, reduced academic and vocational performance, restricted career and personal development, alcohol abuse and depression. As in other anxiety disorders, the anxiety experienced by social phobics is characterized by somatic (bodily sensations), cognitive (thoughts), and overt behavior (avoidance) features. Information on the treatment of social phobia lags far behind that of other phobic conditions. Two very different treatments, drug treatment with beta-adrenergic blocking agents and behavior therapy with desensitization both have shown considerable promise. However, there has been no published attempt to compare these two treatments, or to examine their combined effectiveness in treating social phobia. The proposed study is a treatment comparison of desensitization plus placebo, the beta-blocking drug atenolol, combined desensitization and atenolol, and placebo. One hundred and eighty subjects will participate in a 3 month treatment phase and a 6 month follow-up phase. The results will allow an assessment of the effectiveness of atenolol, desensitization, and the potentially synergistic combination of atenolol plus desensitization. Furthermore, the durability of these treatments will be determined. This study will provide important information on the clinical management of social phobia and the impact of these treatments on social and global functioning.